- 01Homocysteine is a sensitive flag, not a specific diagnosis
It rises whenever the B-vitamin recycling machinery stalls, which happens with low B12, low folate, low B6, kidney disease, thyroid problems, and the common MTHFR gene variant. A high number tells you something is off; it does not tell you what. That is why it is read alongside MMA and kidney function, not alone.
- 02It is a B-vitamin marker, not a heart-disease treatment target
Observational studies link higher homocysteine to more heart attacks and strokes, but the effect is modest and randomized trials that lowered it with B vitamins did not reliably prevent those events. Chasing the number down with supplements is not proven to protect your heart; finding and treating the underlying deficiency is the point.
- 03MMA is the tie-breaker for B12 versus folate
Homocysteine rises with either low B12 or low folate, but methylmalonic acid rises only with low B12. Reading the two together is what turns a non-specific flag into a specific answer about which vitamin is short.
Homocysteine is an amino acid your body makes as it recycles the protein building block methionine, and a high blood level usually means one of the B vitamins that clear it (B12, folate, or B6) is running low, or your kidneys are struggling. It was promoted for years as a heart-disease number to chase, but large trials that lowered it with B vitamins did not cut heart attacks or deliver the heart protection people expected, so it is best read as a B-vitamin flag, not a target to treat.
What is homocysteine?
Homocysteine is a sulfur-containing amino acid, a molecule your cells produce as an intermediate step while processing methionine, an essential amino acid you get from protein in food. Your body does not keep homocysteine around; it either recycles it back into methionine or converts it into another amino acid called cysteine. Both of those exit routes need B vitamins, which is why the level in your blood is a readout of how well that machinery is running.
When any of those clearance routes slows down, homocysteine builds up in the blood. That is the whole reason the test exists: a raised level is a signal that the recycling has stalled somewhere, most often because a required B vitamin is in short supply.
How your body clears homocysteine
How homocysteine is normally cleared, and where it stalls
That two-route design is why homocysteine is sensitive but non-specific. A single high number tells you the recycling has stalled; it does not tell you whether B12, folate, or B6 is the culprit, or whether the real problem is your kidneys.
What does high homocysteine mean?
A high homocysteine means one or more of its clearance routes is not keeping up. In practice the common drivers are low vitamin B12, low folate, low vitamin B6, reduced kidney function, an underactive thyroid, and inherited enzyme variants such as the common MTHFR gene change. Older age nudges it up on its own. Because so many things raise it, an isolated mild elevation is a prompt to look further, not a diagnosis.
Homocysteine rises with low B12, low folate, or low B6, so by itself it flags a problem without naming the cause.
| Tier | Fasting total homocysteine | What it usually reflects |
|---|---|---|
| Normal | About 5 to 15 micromol/L | The typical range in a healthy adult with adequate B vitamins and normal kidney function. 1 |
| Borderline / mild elevation | About 15 to 30 micromol/L | Often low B12 or folate, reduced kidney function, thyroid, or an MTHFR variant; worth working up. 1 |
| Moderate to severe | Above about 30 micromol/L | Prompts a careful search for a clear cause (marked vitamin deficiency, significant kidney disease, or a genetic cause). 1 |
Where an example homocysteine result fallsmicromol/L
What causes high homocysteine?
- Low vitamin B12: stalls the remethylation route. Homocysteine and MMA both tend to rise together when B12 is the problem.
- Low folate: also stalls remethylation, raising homocysteine while MMA usually stays normal.
- Low vitamin B6: stalls the transsulfuration route into cysteine.
- Reduced kidney function: the kidneys clear homocysteine, so chronic kidney disease raises it independent of any vitamin. 1
- Underactive thyroid (hypothyroidism): a recognized cause of a raised level. 1
- MTHFR gene variants: a common inherited change that makes the folate-processing enzyme less efficient can mildly raise homocysteine, especially when folate intake is low.
- Older age: homocysteine tends to drift up with age and declining kidney function, so a mild elevation in an older adult is not automatically a vitamin deficiency.
- Rare inherited homocystinuria: a genetic enzyme defect that causes very high levels from childhood.
Which deficiency is it? B12 vs folate vs kidney vs genetic
Because homocysteine alone cannot name the cause, the useful next step is to read it alongside other results. Methylmalonic acid (MMA) is the tie-breaker for the B12-versus-folate question, because it rises when B12 is missing at the cell level and, unlike homocysteine, does not climb for a folate shortage.
When both MMA and homocysteine are high, that points to B12; when homocysteine is high but MMA is normal, that points to folate.
What a high homocysteine can be pointing at
So the practical read is: a high homocysteine sends you to check vitamin B12 and folate first, with MMA as the confirmatory test for B12, while keeping kidney function, thyroid, and age in the frame. If you want the deeper mechanism of why MMA is the more specific B12 test, that is covered on the methylmalonic acid page.
Homocysteine and heart disease: the honest story
For years homocysteine was marketed as a modifiable heart-disease risk factor. The idea came from observational studies, which do consistently find that people with higher levels have somewhat higher rates of heart attack and stroke. A large meta-analysis pooling many of those studies put the size of the effect on the record.
This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations.Homocysteine Studies Collaboration, JAMA 2002;288:2015-2022 [[4]]
In that analysis, a 25% lower homocysteine was associated with an 11% lower odds of ischemic heart disease (odds ratio 0.89, 95% CI 0.83 to 0.96) and a 19% lower odds of stroke (odds ratio 0.81, 95% CI 0.69 to 0.95). The effect is modest, and it is an association, not evidence that lowering the number helps. 4
That last question was tested directly. Randomized trials gave people B vitamins (folic acid, B12, and B6) to lower homocysteine and then tracked heart attacks and strokes. The HOPE-2 trial lowered homocysteine but did not reduce cardiovascular death or heart attacks, though it did show a reduction in stroke as a secondary outcome. 6 A Cochrane review pooling these trials reached much the same verdict.
Elevated homocysteine tracks heart risk, but the B vitamins that lower it have not cut heart attacks in trials, so it is a marker to read, not a number to chase.
The Cochrane review of homocysteine-lowering trials found no reduction in heart attack or death from any cause, and at most a small effect on stroke. 5 That is the crux of the modern reading: homocysteine can be a marker of underlying risk, but pushing the number down with supplements has not delivered the heart protection people once expected from it.
How to lower homocysteine
If a specific deficiency is found, the fix is treating that deficiency, and that is a decision for your clinician, not a target number to self-manage. Repleting low B12, low folate, or low B6 typically brings homocysteine down, because it reopens the stalled clearance route. That is worth doing to correct the deficiency itself. It is not, based on the trial evidence, a proven way to prevent heart attacks or strokes.
Where diet is the driver, the B vitamins that clear homocysteine come from ordinary foods: folate from leafy greens, legumes, and (in the US) fortified grains; B12 from animal foods; B6 from a wide range of foods. This is background context, not a treatment plan or a dose, and anyone with a high result should work out the specifics with their clinician.
How the test is done
- It is a blood draw, usually ordered on its own or alongside B12 and folate. It is not part of a standard basic metabolic panel, so it has to be requested specifically.
- Fasting is often requested because a recent high-protein meal can nudge the level up, and the sample needs prompt handling in the lab, so follow the exact instructions your lab gives.
- It is a send-out or specialized assay at many labs, so it can cost more than routine bloodwork and coverage varies; ask before assuming it is included.
- Retesting cadence depends on why it was ordered: if a deficiency is being treated, a recheck after the deficiency is corrected (often a few weeks to a few months after starting treatment) shows whether the number responded. Your clinician sets the timing.
Where homocysteine fits with the other B-vitamin markers
| Marker | What it measures | When it wins |
|---|---|---|
| Homocysteine | Whether the B-vitamin recycling machinery is stalled | Sensitive early flag, but non-specific: rises with low B12, folate, OR B6, plus kidney and thyroid |
| Methylmalonic acid (MMA) | Whether B12 is missing at the cell level | Specific confirmation of a real B12 deficiency; separates B12 from folate |
| Serum B12 | Circulating B12, a noisy first-line number | Screening, but has a gray zone that MMA and homocysteine clarify |
| Serum folate | Recent folate intake over days | First-line folate check, though deficiency is now rare after fortification |
For the individual markers, see the vitamin B12 page (the deficiency homocysteine most often signals), the serum folate page (the other deficiency it can signal, and where the folate-masks-B12 trap is covered in full), and the methylmalonic acid page (the confirmatory B12 test that settles which vitamin is low). If a B12 deficiency is confirmed, the vitamin B12 deficiency page explains what that condition actually involves and how it is treated.
Frequently asked
Link · JAMA, 2002Homocysteine and risk of ischemic heart disease and stroke: a meta-analysisThe observational meta-analysis behind the modest heart-risk association, with the per-25%-lower odds ratios quoted above.jamanetwork.com Link · Cochrane Database of Systematic Reviews, 2017Homocysteine-lowering interventions for preventing cardiovascular eventsThe pooled randomized-trial evidence: lowering homocysteine with B vitamins did not reduce heart attack or death, with at most a small effect on stroke.cochranelibrary.com
Citations
- Devalia V, Hamilton MS, Molloy AM (British Committee for Standards in Haematology). Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.
- Stabler SP. Vitamin B12 Deficiency. N Engl J Med. 2013;368(2):149-160.
- Green R, Allen LH, Bjorke-Monsen AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040.
- Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-2022.
- Marti-Carvajal AJ, Sola I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8:CD006612.
- Lonn E, Yusuf S, Arnold MJ, et al (HOPE-2 Investigators). Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354(15):1567-1577.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.
Associations to explore with a clinician, not a diagnosis from a single number.
